Atai Life Sciences EPS - Earnings per Share 2020-2024 | ATAI
Atai Life Sciences eps - earnings per share from 2020 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Atai Life Sciences Annual EPS | |
|---|---|
| 2023 | $-0.25 |
| 2022 | $-0.98 |
| 2021 | $-1.21 |
| 2020 | $-1.83 |
| 2019 | $-0.16 |
| Atai Life Sciences Quarterly EPS | |
|---|---|
| 2024-03-31 | $-0.17 |
| 2023-12-31 | $-0.08 |
| 2023-09-30 | $0.25 |
| 2023-06-30 | $-0.21 |
| 2023-03-31 | $-0.21 |
| 2022-12-31 | $-0.28 |
| 2022-09-30 | $-0.22 |
| 2022-06-30 | $-0.24 |
| 2022-03-31 | $-0.24 |
| 2021-12-31 | $-0.64 |
| 2021-09-30 | $-0.21 |
| 2021-06-30 | $-0.37 |
| 2021-03-31 | $0.01 |
| 2020-12-31 | $-0.89 |
| 2020-09-30 | $-0.92 |
| 2020-06-30 | $-0.18 |
| 2020-03-31 | $0.16 |
| 2019-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.290B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.911B | 10.23 |
| Quest Diagnostics (DGX) | United States | $16.016B | 16.55 |
| DaVita (DVA) | United States | $12.360B | 15.35 |
| Encompass Health (EHC) | United States | $8.670B | 22.19 |
| Chemed (CHE) | United States | $8.544B | 26.48 |
| Elanco Animal Health (ELAN) | United States | $8.401B | 21.80 |
| Option Care Health (OPCH) | United States | $5.051B | 19.12 |
| RadNet (RDNT) | United States | $4.321B | 89.99 |
| Amedisys (AMED) | United States | $3.141B | 22.25 |
| LifeStance Health (LFST) | United States | $2.871B | 0.00 |
| Astrana Health (ASTH) | United States | $2.188B | 29.59 |
| Addus HomeCare (ADUS) | United States | $1.812B | 25.92 |
| U.S Physical Therapy (USPH) | United States | $1.588B | 42.50 |
| Pennant (PNTG) | United States | $0.695B | 36.70 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.560B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.028B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.022B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.012B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.008B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |